Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis

Authors

Leonora Conneely
Kevin Boyd (ORCID: https://orcid.org/0000-0002-5362-6934)
Katy Smith
Giuseppe Bertuglia (ORCID: https://orcid.org/0009-0009-3785-9824)
Christina Messiou (ORCID: https://orcid.org/0000-0002-0557-9379)
Elisa Seneca
Charlotte Pawlyn (ORCID: https://orcid.org/0000-0002-7190-0028)
Martin Kaiser (ORCID: https://orcid.org/0000-0002-3677-4804)
Tracy Thornton
Dima El‐Sharkawi (ORCID: https://orcid.org/0000-0002-2752-5814)
Mikel Valganon Petrizan
Francesca Gay (ORCID: https://orcid.org/0000-0002-8619-412X)
Simon Stern
Tommy Brown
Elilta Samuel

Institutions

Royal Marsden NHS Foundation Trust (GB)
St Helier Hospital (GB)
Epsom and St Helier University Hospitals NHS Trust (GB)
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
Royal Marsden Hospital (GB)

Publication Details

Journal: Haematologica
Published: 2026-08-27
DOI: https://doi.org/10.3324/haematol.2026.301383
Primary Topic: Monoclonal and Polyclonal Antibodies Research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Pfizer
Sanofi
BeiGene
Università degli Studi di Torino

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis

Leonora Conneely, Kevin Boyd, Katy Smith, Giuseppe Bertuglia et al.

Aug 27, 2026

Haematologica

Monoclonal and Polyclonal Antibodies Research

article

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis

Leonora Conneely, Kevin Boyd, Katy Smith, Giuseppe Bertuglia, Christina Messiou, Elisa Seneca, Charlotte Pawlyn, Martin Kaiser, Tracy Thornton, Dima El‐Sharkawi, Mikel Valganon Petrizan, Francesca Gay, Simon Stern, Tommy Brown, Elilta Samuel

August 27, 2026article en

Abstract

No abstract available for this paper.

Haematologica

Royal Marsden NHS Foundation Trust (GB), St Helier Hospital (GB), Epsom and St Helier University Hospitals NHS Trust (GB), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Royal Marsden Hospital (GB)

Amgen, Pfizer, Sanofi, BeiGene, Università degli Studi di Torino

Openalex Percentile: Top 11%

Monoclonal and Polyclonal Antibodies Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis — Leonora Conneely, Kevin Boyd, et al. · Haematologica (2026) | TGRS Research Map | TGRS